6 drug(s) with this reaction
1,987 total reports
Urinary Tract Infection has been reported as an adverse reaction across 6 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,987 adverse event reports mention urinary tract infection in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with urinary tract infection, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have urinary tract infection listed in their FDA adverse event reports, sorted by report count:
In addition to urinary tract infection, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
6 drug(s) manufactured by Chattem Inc have urinary tract infection listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LEVOCETIRIZINE DIHYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE, MENTHOL, CAMPHOR, MENTHOL, and others.
There are a combined 1,987 reports of urinary tract infection across 6 Chattem Inc drug(s) in the FDA adverse event database.